Welcome to the e-CCO Library!

P238: Vitamin D deficiency in inflammatory bowel disease: is malabsorption to blame?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Schembri*, S. Chetcuti, S. Vella, P. Ellul

Created: Friday, 22 February 2019, 9:49 AM
P239 Elderly-onset inflammatory bowel disease is associated with higher risks of infections, cancers and hospitalisation: Results from a territory-wide Hong Kong IBD registry
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.W.Y. Mak1, L.T.C. Ho2, K. Wong1, T.Y. Cheng1, T.C.F. Yip1, W.K. Leung3, M. Li4, F.H. Lo5, K.M. Ng6, S.F. Sze7, C.M. Leung8, S.W.C. Tsang9, E.H.S. Shan10, K.H. Chan11, B.C.Y. Lam12, A.J. Hui13, W.H. Chow14, S.C. Ng1, Hong Kong IBD Registry

Created: Thursday, 30 January 2020, 10:12 AM
P239: A novel user friendly model to identify key predictors of corticosteroid utilization in newly diagnosed patients with ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Patel D.*1, Shah Y.2, Khan N.3

Created: Wednesday, 20 February 2019, 10:36 AM
P239: A study to evaluate uptake of PROMS for IBD patients on Biologics : a sample United Kingdom district general hospital experience.
Year: 2021
Source: ECCO'21 Virtual
Authors: Mahmood, T.(1);Muhammad, Q.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P239: Hospitalisations and characteristics of patients with ulcerative colitis and Crohn’s disease treated with vedolizumab in real-world clinical practice: results from a multicentre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Reynolds1, N. Alam2, M. Raluy2, B. Gardstein1, D. O’Hara3, M. Smyth4, J. M. Khalid*4

Created: Friday, 22 February 2019, 9:49 AM
P239: Incidence of Long COVID and impact of medications on the risk of developing Long COVID in a nationwide cohort of Inflammatory Bowel Disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Khan, N.(1,2)*;Mahmud, N.(1,2);Patel, M.(1);Sundararajan, R.(1);Reinisch, W.(3);
Created: Friday, 14 July 2023, 10:48 AM
P239: Real-life clinical and quality of life outcomes collected remotely from patients with moderate to severe active ulcerative colitis during induction treatment with golimumab in GO OBSERVE
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. Cornillie*1, M. Flamant2, T. Haas3, E. Jörgensen4, A. Schirbel5, A. Khalifa1, M. Ferrante6, M. Govoni7, GO OBSERVE Investigators1

Created: Friday, 22 February 2019, 9:41 AM
P239: The accuracy of intestinal ultrasound as compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileo-colonoscopy
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Carter*, L.H. Katz, E. Bardan, E. Salomon, S. Goldstein, S. Ben Horin, U. Kopylov, R. Eliakim

Created: Thursday, 21 February 2019, 9:14 AM
P239: Ulcerative Colitis Index of Severity is a better predictor of histologic activity than Mayo endoscopic subscore, an Asian cohort study in ulcerative colitis.
Year: 2022
Source: ECCO'22
Authors: Tay, S.(1);Teh, K.K.J.(1);Wang, L.M.(2);Tan, M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P240 CDEIS score of 2 is optimal cut-off associated with lower risk of disease progression in early Crohn’s disease: Data from the CALM study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Ungaro1, R. Jordan2, C. Yzet3, P. Bossuyt4, F. Baert5, T. Vanasek6, G.R. D’Haens7, V. Wilhelmus Joustra7, R. Panaccione8, G. Novacek9, W. Reinisch9, A. Armuzzi10, O. Golovchenko11, O. Prymak11, A. Goldis12, S. Travis13, X. Hébuterne14, M. Ferrante15, G. Rogler16, M. Fumery3, S. Danese17, G. Rydzewska18, B. Pariente19, E. Hertervig20, C. Stanciu21, M. Serrero22, M. Diculescu23, L. Peyrin-Biroulet24, D. Laharie25, J.P. Wright26, F. Gomollón27, G. Irina28, S. Schreiber29, S. Motoya30, P.M. Hellström31, J. Halfvarson32, J.F. Colombel33

Created: Thursday, 30 January 2020, 10:12 AM
P240: Clinical diagnostics of fecal calprotectin: a comparative study of a semi-quantitative rapid test and a quantitative lab test
Year: 2021
Source: ECCO'21 Virtual
Authors: Miettinen, J.(1);Vuolteenaho, O.(2);Hedberg, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P240: Influence of Covid-19 infection in patients with inflamatory bowel disease with biological and no biological therapy
Year: 2022
Source: ECCO'22
Authors: Herrador Paredes, M.(1);Fernández Cano, M.C.(1);Sánchez Capilla, A.D.(1);Martín Rodrírguez, M.D.M.(1);Cabello Tapia, M.J.(1);Redondo Cerezo, E.(1);
Created: Friday, 11 February 2022, 3:52 PM
P240: Low surgery rates first year after diagnosis in Crohn's disease; results from a large population-based inception cohort - the IBSEN III study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lund, C.(1,2)*;Strande, V.(2,3,4);Småstuen, M.C.(1,5);Bengtson, M.B.(6);Cetinkaya, R.B.(7);Detlie, T.E.(2,8);Frigstad, S.O.(9);Medhus, A.W.(1,2);Henriksen, M.(10);Holten, K.I.A.(2,10);Hovde, Ø.(2,11);Huppertz-Hauss, G.(12);Johansen, I.(13,14);Olsen, B.C.(2,12);Opheim, R.(1,14);Pallenschat, J.(15);Perminow, G.(16);Ricanek, P.(4,8);Vatn, S.(8);Aabrekk, T.B.(2,6);Kristensen, V.A.(1,3);Høivik, M.L.(1,2);
Created: Friday, 14 July 2023, 10:48 AM
P240: Microscopic colitis is the most frequent diagnosis of patients with watery chronic diarrhoea and macroscopically normal colonoscopy in a context of clinical practice
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Batista1*, L. Ruiz1, Y. Zabana1, M. Aceituno1, B. Arau1, X. Andújar1, M. Esteve1, F. Fernández-Bañares1,2

Created: Thursday, 21 February 2019, 9:14 AM
P240: Microscopic colitis, are there any predictors?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

I. G. Moraru*1, R. Vadan1, L. Gheorghe2, M. Dumbrava3, G. Becheanu3

Created: Friday, 22 February 2019, 9:49 AM
P240: Presentation and surgical interventions for Crohn's disease with perianal fistula in the biologics era: results from a multicentre study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Black C.1, Pugliese D.2, Sahnan K.3, Armuzzi A.2, Elkady S.M.3, Hart A.L.3, Katsanos K.H.4, Christodoulou D.K.4, Selinger C.5, Maconi G.6, Fiorino G.7, Davidov Y.8, Kopylov U.8, Ben-Horin S.8, Navarro P.9, Bosca-Watts M.M.9, Muscat M.10, Ellul P.10, Karmiris K.11, Allgar V.12, Danese S.7, Fearnhead N.S.13, Sebastian S.*1,14

Created: Wednesday, 20 February 2019, 10:36 AM
P240: Surgical resection in a tertiary IBD centre in Southeastern Brazil: clinical aspects and associated factors
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. da Costa Ferreira*1, L. Cavalcanti Dias Xavier1, P. Maria Lemos1, L. Rose Otoboni Aprile1, B. Bezerra Martins de Oliveira1, I. Steltenpool Tonin Borges1, R. Serafim Parra2, M. Ribeiro Feitosa2, O. Féres2, J. Joaquim Ribeiro da Rocha2, L. E. de Ameida Troncon1

Created: Friday, 22 February 2019, 9:41 AM
P241 Early prediction of outcome in acute severe ulcerative colitis (ASC): comparison of clinical and endoscopic indices at presentation, with day 3 criteria
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Gupta1, W. Mohsen1, A. Adams1, A. Murphy1, D. Sathananthan1, S. Cripps1, O. Brain1, R. Palmer1, T. Ambrose1, B. George2, A. Walsh1, S. Travis1, J. Satsangi1

Created: Thursday, 30 January 2020, 10:12 AM
P241: Advantages of a fully automated chemiluminescent method for therapeutic drug monitoring (TDM) of anti-TNFα in patients with Inflammatory Bowel Diseases.
Year: 2022
Source: ECCO'22
Authors: Cifù, A.(1);Marino, M.(2);Sablich, R.(3);Carletti, M.(4);Blasone, N.(4);Milloch, S.(4);Curcio, F.(1);Fabris, M.(4);
Created: Friday, 11 February 2022, 3:52 PM